Send feedback

A2ML1 p.Asn164=

c.492T>C · rs200136680 · VCV1972029

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 2 submitters
gnomAD v4.1
Rare
very rare (popmax 0.00331%, nfe)

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation/SpliceAI carries the signal.
Splicing
SpliceAIΔ0.23acceptor gain · deltas
Constraint at this position
ConservationphyloP -2.4GERP -2.7
Overall
CADD3.276PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00331% European (non-Finnish) · 39/1,179,974 alleles
Filtering AF 0.00247% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00217%
Overall 0.00254% 41/1,614,018 alleles · very rare
Ancestry group Frequency 1 in
European (non-Finnish)grpmax 0.00331% 30,256
Remaining individualsnot grpmax-eligible 0.0016% 62,494
African / African-American 0.00133% 75,016

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
A2ML1
Protein
p.Asn164=
Coding
c.492T>C
MANE Select
NM_144670
dbSNP
rs200136680
Type
single nucleotide variant
Location
chr12:8835515 (GRCh38)
Gene constraint
LOEUF 0.953 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 80.61 · 5 PDB
Full A2ML1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/a2ml1-p-asn164 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown